Comparison of prazosin and methyldopa in mild to moderate hypertension, a multicenter cooperative study. 1977

W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
January 1984, The American journal of cardiology,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
September 1981, The Practitioner,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
January 1990, Clinical therapeutics,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
January 1978, Current medical research and opinion,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
January 1974, Acta cardiologica,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
February 1979, The Journal of the Association of Physicians of India,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
May 1987, The American journal of cardiology,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
September 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
January 1989, Clinical therapeutics,
W F Bradley, and F G Hoffman, and J C Hutchison, and Z Kalams, and S L Waldron
December 1989, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!